- Filed
- Mar 31, 2021 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | FY 2020 · Mar 25, 2021 | 2.97M sh |
| Shares Diluted restated | FY 2020 · Dec 31, 2019 | 2.91M sh |
| Capex | FY 2020 · Dec 31, 2019 | $142.59K |
| Operating Cash Flow | FY 2020 · Dec 31, 2019 | −$1.46M |
| Cash And Equivalents | FY 2020 · Dec 31, 2019 | $37.74M |
| Cash And Equivalents | FY 2020 · Dec 31, 2018 | $11.09M |
| Total Liabilities | FY 2020 · Dec 31, 2019 | $217.72M |
| Total Assets | FY 2020 · Dec 31, 2019 | $241.8M |
| Eps Diluted restated | FY 2020 · Dec 31, 2019 | $0.27 |
| Eps Basic restated | FY 2020 · Dec 31, 2019 | $0.28 |
| Net Income | FY 2020 · Dec 31, 2019 | $798.47K |
| Cost Of Revenue | FY 2020 · Dec 31, 2019 | $118.39K |
| Stockholders Equity | FY 2020 · Dec 31, 2018 | $22.96M |